The LSU AgCenter has finalized its agreement with GB Sciences Louisiana LLC to operate the center’s medical marijuana business.
GB Sciences Louisiana is a subsidiary of GB Sciences, a Las Vegas cannabis company focused on biopharmaceutical development. The parent company has filed patent applications for using cannabis for chronic pain and heart therapies as well as chronic arthritis, Crohn’s disease, inflammatory bowel disease and asthma.
“It is extremely important that we can provide patients with safe and consistent options to help improve their quality of life,” said Bill Richardson, LSU vice president for agriculture.
In Louisiana, only the LSU AgCenter and Southern University’s AG Center hold licenses to produce medical marijuana. The medication must be in an oil; an oral form, such as pills, sprays or chewables; topical applications; transdermal patches and suppositories.
GB Sciences expects to begin production at an off-campus facility by the middle of next year.
Under the terms of the agreement, the LSU AgCenter will receive $3.4 million or 10 percent of gross revenue, whichever is greater, over five years. GB Sciences will also support LSU AgCenter research through funding for personnel, laboratory research space and equipment plus an additional monetary contribution for research initiatives. [Read more at The Advocate]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
Local government opposition, high taxes and competition from unlicensed businesses are complicating the state’s push to build a thriving legal market. LOS ANGELES — California’s cannabis market is booming nearly five years after voters legalized recreational weed. But there’s a catch: the vast majority of pot sales are still underground. Rather than make cannabis a…
LUXEMBOURG is to become the first European country to permit adult-use cannabis after the Government announced measures to permit households to cultivate up to four domestic plants. The announcement, earlier today, applies to to all citizens over the age of 18 with the new regulations also allowing for the sale and import of seeds. However,…
FRIDAY, Oct. 22, 2021 (HealthDay News) — Researchers may be one step closer to developing the equivalent of a Breathalyzer for detecting marijuana use. In an early study, scientists found that their rapid test was able to reliably detect THC in people’s saliva in under 5 minutes. THC, short for tetrahydrocannabinol, is the active ingredient…
New York Labor Law 201-D This document is intended to address some of the most common situations or questions in the workplace related to adult-use cannabis and the Marijuana Regulation and Taxation Act (“MRTA”). This document does not address the medical use of cannabis. For further assistance with New York Labor Law and the MRTA, please…